Cosmos Health Inc. (COSM)vsNovartis AG ADR (NVS)
COSM
Cosmos Health Inc.
$2.49
-23.15%
HEALTHCARE · Cap: $20.89M
NVS
Novartis AG ADR
$160.50
-0.19%
HEALTHCARE · Cap: $302.86B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 77705% more annual revenue ($57.36B vs $73.73M). NVS leads profitability with a 17.5% profit margin vs -33.1%. NVS earns a higher WallStSmart Score of 48/100 (D+).
COSM
Hold36
out of 100
Grade: F
NVS
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for COSM.
Margin of Safety
-67.6%
Fair Value
$95.76
Current Price
$160.50
$64.74 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 28.8% year-over-year
Mega-cap, among the largest globally
Strong operational efficiency at 34.0%
Every $100 of equity generates 27 in profit
Generating 4.8B in free cash flow
Areas to Watch
Trading at 9.6x book value
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -106.6% — below average capital efficiency
Premium valuation, high expectations priced in
Trading at 8.1x book value
4.7% revenue growth
Grey zone — moderate risk
Comparative Analysis Report
WallStSmart ResearchBull Case : COSM
The strongest argument for COSM centers on Revenue Growth. Revenue growth of 28.8% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Operating Margin, Return on Equity. Profitability is solid with margins at 17.5% and operating margin at 34.0%.
Bear Case : COSM
The primary concerns for COSM are Price/Book, EPS Growth, Market Cap.
Bear Case : NVS
The primary concerns for NVS are P/E Ratio, Price/Book, Revenue Growth.
Key Dynamics to Monitor
COSM profiles as a growth stock while NVS is a value play — different risk/reward profiles.
COSM carries more volatility with a beta of 4.44 — expect wider price swings.
COSM is growing revenue faster at 28.8% — sustainability is the question.
NVS generates stronger free cash flow (4.8B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (48/100 vs 36/100), backed by strong 17.5% margins. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cosmos Health Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?